These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6198127)

  • 21. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentrations of ceftriaxone in serum and gynecological tissues.
    Daschner FD; Petersen EE; Brändle J; Hillemanns HG
    Chemotherapy; 1983; 29(2):153-5. PubMed ID: 6301774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.
    Borner K; Lode H; Hampel B; Pfeuffer M; Koeppe P
    Chemotherapy; 1985; 31(4):237-45. PubMed ID: 4028870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime.
    Korting HC; Abeck D
    Chemotherapy; 1989; 35(6):441-8. PubMed ID: 2515041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR; Srulevitch ES; Jacobson J; Hirschman SZ
    Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.
    Zhou HH; Chan YP; Arnold K; Sun M
    Antimicrob Agents Chemother; 1985 Feb; 27(2):192-6. PubMed ID: 3985603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.
    Scaglione F; De Martini G; Peretto L; Ghezzi R; Baratelli M; Arcidiacono MM; Fraschini F
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2292-4. PubMed ID: 9333066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic prevention in hysterectomy. Effectivity of a single preoperative ceftriaxon dose].
    Petersen EE; Daschner FD; Pelz K; Birmelin G; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1983 Aug; 43(8):492-7. PubMed ID: 6311659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of ceftriaxone in the peripheral venous serum, uterine arterial serum and intrapelvic genital organs].
    Miyakawa I; Taniyama K; Nagai K; Yasuda H; Mori N
    Jpn J Antibiot; 1984 Dec; 37(12):2420-6. PubMed ID: 6098738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Passage of cefotiam into prostatic tissue].
    Charton M; Panis G; Brisset JM; Veillon B; Vallancien G; Selles JP
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):530-2. PubMed ID: 3911149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1984 Dec; 37(12):2355-63. PubMed ID: 6098729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on cefmenoxine concentration in prostatic tissue and bladder wall].
    Miyagawa I; Goto H; Nakashita E; Fukuda K; Hamamoto R; Inoue A; Miyake S; Nishida H; Umano I; Nakamura I
    Jpn J Antibiot; 1984 May; 37(5):787-90. PubMed ID: 6090720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of prostatic tissue levels of cefodizime (CDZM)].
    Yamada Y; Fukatsu H; Kamijo A; Mizumoto H; Taki T; Mitsui K; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y
    Hinyokika Kiyo; 1994 Apr; 40(4):365-9. PubMed ID: 7514846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral resection of the prostate.
    Finkelstein LH; Arsht DB; Manfrey SJ; Childs S
    Am J Surg; 1984 Oct; 148(4A):19-21. PubMed ID: 6091475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of diffusion of cefotiam into myocardial tissue].
    Hibi M; Abe T; Murase M; Tanaka M; Takeuchi E; Iyomasa Y
    Jpn J Antibiot; 1983 Oct; 36(10):2671-4. PubMed ID: 6325735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
    De Marco A; Manca B
    Ann Osp Maria Vittoria Torino; 1983; 26(1-6):91-6. PubMed ID: 6093666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis.
    Ti TY; Fortin L; Kreeft JH; East DS; Ogilvie RI; Somerville PJ
    Antimicrob Agents Chemother; 1984 Jan; 25(1):83-7. PubMed ID: 6322683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology].
    Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Dec; 37(12):2304-19. PubMed ID: 6098723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.